APAC The global AI-in-clinical-trials market is forecast to grow at a 22.6 percent CAGR through 2030, reaching roughly USD 6.5 billion, as sponsors push CROs to demonstrate concrete efficiency gains rather than incremental process tweaks. That growth is already visible on the ground in APAC: AI has moved well beyond the…
Germany Collaboration across institutions is not optional – it is necessary. The pace and complexity of the challenges demand it. As CEO of TUM University Hospital Munich, Dr med Martin Siess is trying to close a gap that has long dogged German medicine: strong basic research that rarely makes it to…
Korea I believe we can position Korea as a true global leader in biohealth innovation Lee Hyung Hoon, Vice Minister at Korea’s Ministry of Health and Welfare, outlines his vision for strengthening universal healthcare while positioning Korea as a global biohealth leader. He discusses AI-driven healthcare, regulatory reform, regional access, supply…
Germany We need to bring together expertise in medicine, bioengineering, production technology and artificial intelligence Germany has the scientific expertise and clinical infrastructure to lead in cell and gene therapy, yet turning that strength into therapies that reach patients quickly and at scale remains a critical challenge. Dr Ulrike Köhl examines…
Germany The opportunity is not simply to replicate the US model, but to understand what works in each system and build on the strengths we already have in Europe After almost three decades in the US, Prof. Maike Sander returned to Germany with first-hand experience of an ecosystem where scientific discovery,…
Korea Yeul Hong Kim, R&D President of Yuhan, discusses the company’s transformation from a traditional Korean pharmaceutical business into an increasingly global innovator. He outlines Yuhan’s open innovation strategy, pipeline focus, investment in new modalities and AI-driven discovery, and its approach to global partnerships. Kim also discusses Korea’s pharmaceutical landscape, pricing…
Global Five conferences, anxiety spreading across five continents, one unmistakable pattern: the global pharmaceutical industry is transforming at a dizzying pace. From Philadelphia to Geneva, from Istanbul to Chicago and London, the Shawview Consulting team picked up the same recurring threads in every panel and hallway conversation: AI and real-world data…
USA Mohit Manrao, SVP and Head of US Oncology at AstraZeneca, leads the company’s effort to drive impact for cancer patients across the US. He elaborates on what it means to realise AstraZeneca’s bold ambition to eliminate cancer as a cause of death and shares how this mission goes beyond developing…
Japan We have evolved well beyond the traditional CRO model Global biopharma companies are looking at Japan through a different lens, seeking partners that can navigate an increasingly complex regulatory landscape while supporting integrated development across Asia. At the heart of that evolution is CMIC, whose President and Representative Executive Officer,…
USA As precision medicine forces biopharma to rethink how it builds, runs, and scales laboratory and manufacturing infrastructure, the industry’s next competitive advantage will be found not in discovery, but in operational execution. Few are better positioned to make that argument than Michael Stubblefield, recently appointed CEO of PerkinElmer, who is…
USA You cannot choose between performing and transforming. The organisations that succeed can do both As AI, shifting healthcare policy, growing pressure around affordability and access, and rapidly evolving models of commercialisation reshape the pharmaceutical industry, Deborah Glasser reflects on how Sanofi is positioning its specialty care business for the next…
Global Across the Global South, hundreds of millions of people live without reliable access to basic healthcare. Too few doctors, too little data, and systems too fragile to scale. However, as Capria Ventures’ Francis Perelman outlines, a new wave of AI-native startups is building for precisely those conditions, deploying tools that…
See our Cookie Privacy Policy Here
